Incidence and natural history of Paget's disease of bone in England and Wales.
about
Bisphosphonates for Paget's disease of bone in adultsAminobisphosphonates versus other active treatment for Paget's disease of the bone in adultsThe fracture mechanics of human bone: influence of disease and treatmentPathobiology of Paget's Disease of BoneNeighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activityGenetic association study of UCMA/GRP and OPTN genes (PDB6 locus) with Paget's disease of boneProtocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they wUbiquitin-mediated signalling and Paget's disease of bone.Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they weValidity of diagnostic coding within the General Practice Research Database: a systematic reviewA FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis.Paget's disease population analysis within Rheumatology Outpatient of the ASL of Biella (Piedmont Region, Italy).Emerging strategies and therapies for treatment of Paget's disease of bone.Paget's Disease of Bone among Various Ethnic Groups.Paget disease of the bone: does it exist in Saudi Arabia?CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclastsPaget disease of bone.Mechanisms of disease: genetics of Paget's disease of bone and related disorders.Use of zoledronic acid in the treatment of Paget's disease.Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders.Nonmalignant complications of Paget's disease.Is the prevalence of Paget's disease of bone decreasing?The spine in Paget's diseaseMorbidity and mortality associated with Paget's disease of bone: a population-based study.The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget's Disease in a United States Cohort.Cellular and molecular biology of optineurin.Zoledronic acid for treatment of Paget's disease of bone.Current options for the treatment of Paget's disease of the bone.Epidemiology and pathology of Paget's disease of bone - a review.Clinical and Genetic Advances in Paget's Disease of Bone: a Review.Dickkopf-1 as a potential therapeutic target in Paget's disease of bone.Asymptomatic Paget's bone disease in ethnic Thais: a series of four case reports and a review of the literature.Genetic determinants of Paget's disease of bone.Pharmacotherapy of Paget's disease of bone.Pathogenesis of Paget disease of bone.Paget's disease of bone: clinical review and update.Diagnosis and treatment of Paget's disease of bone: a mini-review.Republished: Paget's disease of bone: clinical review and update.Clinical presentation of Paget's disease: evaluation of a contemporary cohort and systematic review.Clinical characteristics and evolution of giant cell tumor occurring in Paget's disease of bone.
P2860
Q24193330-913F002C-2C6B-4FE1-B8DA-116FD4F7C885Q24246336-634CCCB7-5CF3-4A73-9A2E-669A829ECF40Q26784190-8B20CFED-4F71-4E6A-A0C0-D47F4566682AQ26824476-ACA194AA-46E4-46C1-B43B-710A4617CAC1Q28510813-EA983631-B399-40EF-AE09-9EB52F9DDFD7Q28710374-179C89E8-EC6C-417B-9CE3-4ABC965AA63DQ33246170-168714B1-84AB-4C8A-8B40-AD799C1A41E3Q33307880-EB9DE49A-A12B-4C09-B2AD-22F73DED729CQ33338671-83E67A55-8E39-48E4-B4F2-9E79901FA70AQ33689383-12910003-0CD4-4D16-B1BB-82DCF7A257C7Q33754082-DFFDA4A5-F1D4-484B-971C-C2BBD186C5DBQ33781630-E6BD5428-0D71-4FD3-A7C7-7A6D2F8C0EC8Q34987305-1A7DF33A-6D3C-4559-A754-0BF932262FD6Q35054046-F6C16F04-86D0-45EE-8709-FC479DBA7E75Q35059610-4D6B7FB2-3F7D-461B-804D-5E968256C0C4Q35894360-F97365D5-843C-4482-92E5-D92AD07DC8AAQ36029217-5F04E206-6992-421A-9A3D-19FEFF419D1FQ36577488-27FD5A9D-7FED-4346-8CC3-BC755032CE18Q36645767-15BB5D4E-0673-4684-B664-BD48C3565B91Q36710160-DA4E7EC9-0F15-442B-8253-38BF5545E424Q36710171-EF452F50-911D-49E9-870F-9FFCA04F61E7Q36710188-83345F67-0BDF-495E-AE16-28E6ED2135ECQ36780812-9D72BAC6-E8C1-42E1-B15E-835EC68F1271Q36835956-6BEDB009-9DE8-487E-9940-610F260AC7A3Q36843566-0D793C6F-F447-441A-B35F-8A6777C60A9BQ36905164-A9D0FB90-B195-4CE4-A979-AAF758B8BE6CQ36979355-E9285360-799C-4528-982D-D6340245670EQ37358122-9D957698-3C60-4921-B266-2DE21A6589D5Q37607309-31A76DEE-945D-48F9-B1F3-848E89F161FBQ37642222-3DBD3627-B080-4D31-B56F-723FA1951B2EQ37670256-A4A6E33A-9B8C-49EC-8B0F-BA5E2B93BE2AQ37956225-34BC01E7-5767-4889-97D9-BF7D2F9AC594Q37968682-C109E3A2-66BF-40AB-AF3E-904530BDDC5EQ37984490-1EA1E9EE-3951-4B39-9E14-1768AA1B8687Q38006389-C2F05490-D488-458D-85DA-0CAC1C031034Q38138531-3435A57F-7FFA-4E00-8227-1780ADECA279Q38171737-C0788D32-5372-4157-ADD3-8BC52CCE558BQ38212331-18B22F9F-9626-4136-A9C4-986FC49D791BQ38243734-C168236E-8009-4442-A8EF-7E776BBBEC52Q38246759-340F592D-F213-4BF6-80AC-ACAB18DAD69A
P2860
Incidence and natural history of Paget's disease of bone in England and Wales.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Incidence and natural history of Paget's disease of bone in England and Wales.
@en
Incidence and natural history of Paget's disease of bone in England and Wales.
@nl
type
label
Incidence and natural history of Paget's disease of bone in England and Wales.
@en
Incidence and natural history of Paget's disease of bone in England and Wales.
@nl
prefLabel
Incidence and natural history of Paget's disease of bone in England and Wales.
@en
Incidence and natural history of Paget's disease of bone in England and Wales.
@nl
P2093
P50
P1476
Incidence and natural history of Paget's disease of bone in England and Wales
@en
P2093
P2860
P304
P356
10.1359/JBMR.2002.17.3.465
P577
2002-03-01T00:00:00Z